Dr. Toyoda received his MD from Kobe University School of Medicine in 1990 and his PhD from Kobe University Graduate School of Medicine in 1997. He is certified through the Japanese Boards of Surgery, Thoracic Surgery and Cardiovascular Surgery. His primary clinical and research field of interest is surgery for advanced cardiopulmonary diseases including coronary bypass surgery, valve repair and replacement, pulmonary thromboendarterectomy, ventricular assist device, extracorporeal membrane oxygenation, heart transplantation, lung transplantation and heart-lung transplantation.
Dr. Toyoda received his MD from Kobe University School of Medicine in 1990 and his PhD from Kobe University Graduate School of Medicine in 1997. He is certified through the Japanese Boards of Surgery, Thoracic Surgery and Cardiovascular Surgery. His primary clinical and research field of interest is surgery for advanced cardiopulmonary diseases including coronary bypass surgery, valve repair and replacement, pulmonary thromboendarterectomy, ventricular assist device, extracorporeal membrane oxygenation, heart transplantation, lung transplantation and heart-lung transplantation.
Titular Professor of Clinical & Experimental Cardiology. Research Director at East Boston University (on voluntary leave), Hartford University (on voluntary leave) and Murcia University. C.S. Abanilla (currently). Usual Director of Doctoral Theses on Clinical and Experimental Cardiology. Education and Research of Heart. Advisor, Editorial Board member and Reviewer of several scientific committees from several Institutions and specialized Journals. Has published several Textbooks, Clinical works and Clinical trials on his research field. Currently, he is the Research Director from his Institutions. Research interest include Clinical & Experimental Cardiology.
Titular Professor of Clinical & Experimental Cardiology. Research Director at East Boston University (on voluntary leave), Hartford University (on voluntary leave) and Murcia University. C.S. Abanilla (currently). Usual Director of Doctoral Theses on Clinical and Experimental Cardiology. Education and Research of Heart. Advisor, Editorial Board member and Reviewer of several scientific committees from several Institutions and specialized Journals. Has published several Textbooks, Clinical works and Clinical trials on his research field. Currently, he is the Research Director from his Institutions. Research interest include Clinical & Experimental Cardiology.
Dr. Sadashiva S. Karnik is a Professor (Adjunct) at the Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University. He has been associated with research on GPCR structure, function, and signal transduction. His team is particularly active in the area of mechanism action of ARB and ACE inhibitors, pharmacogenomics and genetic variation in population.
Dr. Sadashiva S. Karnik is a Professor (Adjunct) at the Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University. He has been associated with research on GPCR structure, function, and signal transduction. His team is particularly active in the area of mechanism action of ARB and ACE inhibitors, pharmacogenomics and genetic variation in population.
Dr. Paolo Angelini was Born in Torino , Italy, Graduated Medical Doctor in Milan, Italy (State University). He completed his Cardiology training at the Institute Nacional de cardiologia, Mexico City and the Baylor Cleege of Medicne, Houston, Texas (Texas Heart Institute). Presentli he is the Medical Director, Center for Coronary Artery Anomalies at THI and Clinical Professor, Medicine. Baylor College of Medicine. He is the Author of more than 300 papers; 2 single-author Books; 10 Book chapters, Editor of the Section on Coronary Anomalies at The Texas Hert Institute Journal, Reviewer for more than 10 magazines. His current main research
Dr. Paolo Angelini was Born in Torino , Italy, Graduated Medical Doctor in Milan, Italy (State University). He completed his Cardiology training at the Institute Nacional de cardiologia, Mexico City and the Baylor Cleege of Medicne, Houston, Texas (Texas Heart Institute). Presentli he is the Medical Director, Center for Coronary Artery Anomalies at THI and Clinical Professor, Medicine. Baylor College of Medicine. He is the Author of more than 300 papers; 2 single-author Books; 10 Book chapters, Editor of the Section on Coronary Anomalies at The Texas Hert Institute Journal, Reviewer for more than 10 magazines. His current main research interests include Coronary artery anomalies; Hyperthrophic cardiomyopathy; Coronary spasm; Takotsubo cardiomyopathy.
Dr. Rosendorff is a Professor in the Department of Medicine, Icahn School of Medicine at Mount Sinai, and the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josee and HenryR. Kravis Center for Cardiovascular Health, Mount Sinai Medical Center, New York, NY, U.S.A. He is also Director, Graduate Medical Education, VA Medical Center, Bronx, NY. He has authored three textbooks and over 250 peer-reviewed research papers and book chapters on the subjects of hypertension, vascular biology, cardiovascular pharmacology, coronary blood flow, the cerebral circulation, and geriatric cardiology. He has lectured nationally and internationally on the topics of vascular biology
Dr. Rosendorff is a Professor in the Department of Medicine, Icahn School of Medicine at Mount Sinai, and the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josee and HenryR. Kravis Center for Cardiovascular Health, Mount Sinai Medical Center, New York, NY, U.S.A. He is also Director, Graduate Medical Education, VA Medical Center, Bronx, NY. He has authored three textbooks and over 250 peer-reviewed research papers and book chapters on the subjects of hypertension, vascular biology, cardiovascular pharmacology, coronary blood flow, the cerebral circulation, and geriatric cardiology. He has lectured nationally and internationally on the topics of vascular biology and atherogenesis, preventive cardiology, especially as it relates to hypertension and lipid disorders, and acute coronary syndrome and heart failure.
Dr. Yochai Birnbaum is a Professor of Medicine in Section of Cardiology at Baylor College of Medicine. He is serving the John S. Dunn Chair in Cardiology Research and Education. Board certifications at American Board of Internal Medicine, Cardiovascular Disease. Residency of Internal Medicine, A. Kaplan Hospital, Rabin Medical Center, Petah Tikva, Israel. Fellowships include Cardiology, Cedars-Sinai Medical Center, Good Samaritan Hospital, Los Angeles, CA. His research interests include Clinical electrocardiography, Protection against ischemia-reperfusion injury, Pleiotropic effects of anti-diabetic agents and statins, Diabetic heart disease, Polyunsaturated fatty acids- mechanisms of action, and Statins induced glucose intolerance- mechanisms of action.
Dr. Yochai Birnbaum is a Professor of Medicine in Section of Cardiology at Baylor College of Medicine. He is serving the John S. Dunn Chair in Cardiology Research and Education. Board certifications at American Board of Internal Medicine, Cardiovascular Disease. Residency of Internal Medicine, A. Kaplan Hospital, Rabin Medical Center, Petah Tikva, Israel. Fellowships include Cardiology, Cedars-Sinai Medical Center, Good Samaritan Hospital, Los Angeles, CA. His research interests include Clinical electrocardiography, Protection against ischemia-reperfusion injury, Pleiotropic effects of anti-diabetic agents and statins, Diabetic heart disease, Polyunsaturated fatty acids- mechanisms of action, and Statins induced glucose intolerance- mechanisms of action.
Wilbert S. Aronow, MD is Professor of Medicine at New York Medical College. He has edited 12 books and is author or coauthor of 1, 370 papers, 231 commentaries or Letters to the Editor, and 965 abstracts .He contributed to the 2010 update of the American Medical Directors Association guidelines for heart failure in the long-term care setting. He was Co-Chair of the American College of Cardiology Foundation/American Heart Association 2011 expert consensus document on hypertension in the elderly and is currently a member of the writing group for the American Heart Association/American College of Cardiology Foundation/American Society of Hypertension
Wilbert S. Aronow, MD is Professor of Medicine at New York Medical College. He has edited 12 books and is author or coauthor of 1, 370 papers, 231 commentaries or Letters to the Editor, and 965 abstracts .He contributed to the 2010 update of the American Medical Directors Association guidelines for heart failure in the long-term care setting. He was Co-Chair of the American College of Cardiology Foundation/American Heart Association 2011 expert consensus document on hypertension in the elderly and is currently a member of the writing group for the American Heart Association/American College of Cardiology Foundation/American Society of Hypertension scientific statement on treatment of hypertension in the management of ischemic heart disease. He has been a consultant to the American College of Physicians Information and Educational Resource (PIER) on the module of aortic stenosis. He is currently a member of the Board of Directors of the American Society of Preventive Cardiology and a member of the American College of Chest Physicians Cardiovascular Disease, Hypertension, and Cardiovascular Surgery Network Steering Committee. He has been a member of 97 editorial boards of medical journals.
Dr. Robert Dieter is a cardiologist in Maywood, Illinois and is affiliated with multiple hospitals in the area, including Edward Hines, Jr. Veterans Affairs Hospital and Loyola University Medical Center. He received his medical degree from University of Illinois College of Medicine and has been in practice for 18 years.
Dr. Robert Dieter is a cardiologist in Maywood, Illinois and is affiliated with multiple hospitals in the area, including Edward Hines, Jr. Veterans Affairs Hospital and Loyola University Medical Center. He received his medical degree from University of Illinois College of Medicine and has been in practice for 18 years.
Dr. Shah, a native of Srinagar, Kashmir, is a world renowned clinician, teacher and clinical and translational science cardiovascular investigator at Cedars Sinai Medical Center where he has led the Division for the past nearly 20 years. His major research contributions have been in acute coronary syndromes, cardiovascular disease prevention, in the clinical arena, and atherosclerosis in the basic arena.
Dr. Shah, a native of Srinagar, Kashmir, is a world renowned clinician, teacher and clinical and translational science cardiovascular investigator at Cedars Sinai Medical Center where he has led the Division for the past nearly 20 years. His major research contributions have been in acute coronary syndromes, cardiovascular disease prevention, in the clinical arena, and atherosclerosis in the basic arena.
Dr. Cha is currently a cardiologist, professor in the Division of Cardiovascular Diseases, Department of Medicine at the Mayo Clinic School of Medicine, Rochester, MN. She is the Co-director of Device Service and the Heart Rhythm Research, at the Mayo Clinic. Her primary clinical responsibilities are in the areas of cardiac arrhythmias, engaging full range of catheter-based ablation therapy, complex ablation, device implant and lead extraction. She is a Fellow of both the American College of Cardiology, and the Heart Rhythm Society. She is the member of Communication Committee at Heart Rhythm Society. She has been an
Dr. Cha is currently a cardiologist, professor in the Division of Cardiovascular Diseases, Department of Medicine at the Mayo Clinic School of Medicine, Rochester, MN. She is the Co-director of Device Service and the Heart Rhythm Research, at the Mayo Clinic. Her primary clinical responsibilities are in the areas of cardiac arrhythmias, engaging full range of catheter-based ablation therapy, complex ablation, device implant and lead extraction. She is a Fellow of both the American College of Cardiology, and the Heart Rhythm Society. She is the member of Communication Committee at Heart Rhythm Society. She has been an Established and well-recognized Investigator of the American Heart Association and the Mayo Clinic School of Medicine. Her principal research interests are focused on the technique and outcome of atrial fibrillation and ventricular tachycardia ablation, sudden cardiac death, cardiac resynchronization therapy, and device management. She has published over 100 peer-reviewed articles in NEJM, Circulation, JACC, HR and other medical Journals, and many book chapters. She is actively involved in resident and cardiology fellow education at Mayo Clinic and educational programs internationally.
Dr. Frank Marchlinski is currently a Professor of Medicine and the Director of Electrophysiology, University of Pennsylvania Health Care System. He is a graduate of the University of Pennsylvania School of Medicine. He completed his postdoctoral internal medicine and cardiology/electrophysiology fellowship training at the Hospital of the University of Pennsylvania. He has authored or co-authored over 300 original articles and over 150 book chapters, reviews, and editorials on a variety of topics in cardiac electrophysiology. His primary investigative efforts have been related to the characterization of the substrate and mechanisms of arrhythmias, efforts to
Dr. Frank Marchlinski is currently a Professor of Medicine and the Director of Electrophysiology, University of Pennsylvania Health Care System. He is a graduate of the University of Pennsylvania School of Medicine. He completed his postdoctoral internal medicine and cardiology/electrophysiology fellowship training at the Hospital of the University of Pennsylvania. He has authored or co-authored over 300 original articles and over 150 book chapters, reviews, and editorials on a variety of topics in cardiac electrophysiology. His primary investigative efforts have been related to the characterization of the substrate and mechanisms of arrhythmias, efforts to improve ECG, imaging, and catheter based arrhythmia/ substrate localizing techniques, and efforts to create novel/improved ablation strategies for the treatment of atrial and ventricular arrhythmias.
Dr. Jon C. George, MD completed his medical training at University of Cincinnati College of Medicine in Cincinnati, Ohio; residency and fellowship training at University Hospitals Case Medical Center in Cleveland, Ohio; and subspecialty fellowship training at Temple University Hospital in Philadelphia, Pennsylvania. He serves as the Director of Clinical Research and Assistant Director of the Cardiac Catheterization Laboratory at Deborah Heart and Lung Center in Browns Mills, New Jersey, Adjunct Research Instructor at Temple University School of Medicine in Philadelphia, Pennsylvania, and Clinical Professor of Medicine at Philadelphia College of Osteopathic Medicine in Pennsylvania.
Dr. Jon C. George, MD completed his medical training at University of Cincinnati College of Medicine in Cincinnati, Ohio; residency and fellowship training at University Hospitals Case Medical Center in Cleveland, Ohio; and subspecialty fellowship training at Temple University Hospital in Philadelphia, Pennsylvania. He serves as the Director of Clinical Research and Assistant Director of the Cardiac Catheterization Laboratory at Deborah Heart and Lung Center in Browns Mills, New Jersey, Adjunct Research Instructor at Temple University School of Medicine in Philadelphia, Pennsylvania, and Clinical Professor of Medicine at Philadelphia College of Osteopathic Medicine in Pennsylvania.
Dr Fischell is Professor of Medicine at Michigan State University and Medical Director of the Department of Cardiovascular Research as well as Director of the Interventional Cardiology Fellowship Program at the Borgess Heart Institute in Kalamazoo, Michigan. He also has an active practice as an interventional cardiologist at the Borgess Heart Institute in Kalamazoo.
Dr Fischell is Professor of Medicine at Michigan State University and Medical Director of the Department of Cardiovascular Research as well as Director of the Interventional Cardiology Fellowship Program at the Borgess Heart Institute in Kalamazoo, Michigan. He also has an active practice as an interventional cardiologist at the Borgess Heart Institute in Kalamazoo.
Dr. Maythem Saeed received his PhD degree in 1983 from the Department of Applied Physiology, Freiburg University, West Germany. In 1990, he was appointed as Assistant Professor. His research is focused on cardiac MRI, MDCT and MR-guided interventions. Currently, Dr. Saeed is a professor and Co-Director of Interventional Radiology Laboratory at the Department of Radiology and Biomedical Imaging, University of California San Francisco, CA, USA.
Dr. Maythem Saeed received his PhD degree in 1983 from the Department of Applied Physiology, Freiburg University, West Germany. In 1990, he was appointed as Assistant Professor. His research is focused on cardiac MRI, MDCT and MR-guided interventions. Currently, Dr. Saeed is a professor and Co-Director of Interventional Radiology Laboratory at the Department of Radiology and Biomedical Imaging, University of California San Francisco, CA, USA.
Dr. Ghali is Professor of Medicine at Mercer University. He is the Associate Chair for Clinical Research and Chief of Cardiology. He received his MD degree from Damascus University in Syria. He is board certified in internal medicine and cardiovascular medicine. As principal investigator, Dr. Ghali has conducted over 200 clinical trials predominantly in heart failure and has contributed to the medical literature more than 200 publications, predominantly in the field of heart failure. He came to Mercer from Detroit where he held the positions of Director of Cardiovascular clinical trials and the heart failure program at the
Dr. Ghali is Professor of Medicine at Mercer University. He is the Associate Chair for Clinical Research and Chief of Cardiology. He received his MD degree from Damascus University in Syria. He is board certified in internal medicine and cardiovascular medicine. As principal investigator, Dr. Ghali has conducted over 200 clinical trials predominantly in heart failure and has contributed to the medical literature more than 200 publications, predominantly in the field of heart failure. He came to Mercer from Detroit where he held the positions of Director of Cardiovascular clinical trials and the heart failure program at the Cardiovascular Institute, Detroit Medical Center, Chief of Cardiology, Detroit Receiving Hospital and Associate Chair for Research at Wayne State University. His research interests are heart failure, clinical trials and race/ethnicity.
Dr. Han is the Zachry Endowed Chair and Professor of Mechanical and Biomedical Engineering at the University of Texas at San Antonio (UTSA). He received his Ph.D. degree in Solid Mechanics/Biomechanics from Xi′an Jiaotong University in China with joint training from the University of California at San Diego under the tutelage of Professor YC Fung. His research interests are in the area of cardiovascular biomechanics including arterial wall remodeling due to hemodynamic changes and left ventricular remodeling post myocardial infarction aging, and diastolic heart failure. He is a Fellow of American Heart Association (AHA), American Society of Mechanical Engineers (ASME),
Dr. Han is the Zachry Endowed Chair and Professor of Mechanical and Biomedical Engineering at the University of Texas at San Antonio (UTSA). He received his Ph.D. degree in Solid Mechanics/Biomechanics from Xi′an Jiaotong University in China with joint training from the University of California at San Diego under the tutelage of Professor YC Fung. His research interests are in the area of cardiovascular biomechanics including arterial wall remodeling due to hemodynamic changes and left ventricular remodeling post myocardial infarction aging, and diastolic heart failure. He is a Fellow of American Heart Association (AHA), American Society of Mechanical Engineers (ASME), College of Fellows of American Institute for Medical and Biological Engineering (AIMBE), and an Associate Editor of the ASME Journal of Biomechanical Engineering.
Professor GF Watts, DSc PhD DM FRACP FRCP, has been a senior academic in the School of Medicine and Pharmacology at the University of Western Australia and Consultant Physician at the Royal Perth Hospital since 1994. His clinical and research specialty encompasses cardiometabolic disorders. A graduate of Imperial College in the University of London, Professor Watts received his clinical and research training in university teaching hospitals in the United Kingdom.
Professor GF Watts, DSc PhD DM FRACP FRCP, has been a senior academic in the School of Medicine and Pharmacology at the University of Western Australia and Consultant Physician at the Royal Perth Hospital since 1994. His clinical and research specialty encompasses cardiometabolic disorders. A graduate of Imperial College in the University of London, Professor Watts received his clinical and research training in university teaching hospitals in the United Kingdom.
Dr. Peifeng Li is currently a Professor of Medicine and Dean of Institute for Translational Medicine at Qingdao University, China. Dr. Li once served as Medical Researcher at Max-Delbruck Center for Molecular Medicine in Germany for ten years. He was elected to the “Hundred-Talent Program (Chinese Academy of Sciences)”, China. He has served as a reviewer for many international foundations. He is serving as an editor for several journals like Dataset Papers in Biology, Journal of Clinical and Experimental Cardiology, Journal of Cardiology and Therapy, and Journal of Geriatric Cardiology. He is an associate editor for Cardiovascular Regenerative Medicine.
Dr. Peifeng Li is currently a Professor of Medicine and Dean of Institute for Translational Medicine at Qingdao University, China. Dr. Li once served as Medical Researcher at Max-Delbruck Center for Molecular Medicine in Germany for ten years. He was elected to the “Hundred-Talent Program (Chinese Academy of Sciences)”, China. He has served as a reviewer for many international foundations. He is serving as an editor for several journals like Dataset Papers in Biology, Journal of Clinical and Experimental Cardiology, Journal of Cardiology and Therapy, and Journal of Geriatric Cardiology. He is an associate editor for Cardiovascular Regenerative Medicine.
Giuseppe De Luca, MD, PhD, is Chief of Interventional Cardiology at the Azienda Ospedaliera-Universitaria Maggiore della Carita in Novara, Italy. Having performed over 6,000 coronary angioplasties, Prof.. De Luca is a major worldwide expert in the setting of acute myocardial infarction. He has served as member of the Scientific Committee of the European Association of Percutaneous Coronary Intervention (EAPCI) (2010-2011) and the recipient of several prestigious international scientific awards, including the Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award. An author of 192 peer-reviewed journal publications, Prof. De Luca is Aggregate Professor of Cardiology at Eastern Piedmont University.
Giuseppe De Luca, MD, PhD, is Chief of Interventional Cardiology at the Azienda Ospedaliera-Universitaria Maggiore della Carita in Novara, Italy. Having performed over 6,000 coronary angioplasties, Prof.. De Luca is a major worldwide expert in the setting of acute myocardial infarction. He has served as member of the Scientific Committee of the European Association of Percutaneous Coronary Intervention (EAPCI) (2010-2011) and the recipient of several prestigious international scientific awards, including the Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award. An author of 192 peer-reviewed journal publications, Prof. De Luca is Aggregate Professor of Cardiology at Eastern Piedmont University. He is Director of the University Laboratory of Molecular Cardiology, where he is currently conducting several studies on platelets, pharmacogenomics, genetic predisposition to atherosclerosis, thrombosis, no-reflow phenomenon, and left ventricular remodeling after STEMI.
Dr. Sung, Professor of Medicine, is the director of cardiology department at the Sungkyunkwan University, Kangbuk Samsung hospital. He received his MD and PHD degree from Hanyang University in Korea. He, as a post doctor, conducted training course in Clinical Cardiology, Stanford University, USA. As principal investigator, Dr. Sung has conducted over 80 clinical studies predominantly in preventive cardiology and metabolic syndrome. His clinical areas of interest include adult general cardiology,hypertension and metabolic syndrome. He is an active investigator in the risk factors, biomarkers and pathogenesis of atherosclerosis, regulation and function of lipoproteins, lipid-lowering drugs,
Dr. Sung, Professor of Medicine, is the director of cardiology department at the Sungkyunkwan University, Kangbuk Samsung hospital. He received his MD and PHD degree from Hanyang University in Korea. He, as a post doctor, conducted training course in Clinical Cardiology, Stanford University, USA. As principal investigator, Dr. Sung has conducted over 80 clinical studies predominantly in preventive cardiology and metabolic syndrome. His clinical areas of interest include adult general cardiology,hypertension and metabolic syndrome. He is an active investigator in the risk factors, biomarkers and pathogenesis of atherosclerosis, regulation and function of lipoproteins, lipid-lowering drugs, insulin resistance and hypertension.
Garth Graham, MD, MPH, is board certified in internal medicine and cardiology and previously served as deputy assistant secretary in the U.S. Department of Health and Human Services and assistant dean for health policy and chief of health services research at the University of Florida. Dr. Graham holds a MD and a MPH from Yale University and did his medicine training at Massachusetts General Hospital and cardiology training at Johns Hopkins. His clinical interests are in population health management of cardiovascular disease, post PCI risk factor modification and health disparities.
Garth Graham, MD, MPH, is board certified in internal medicine and cardiology and previously served as deputy assistant secretary in the U.S. Department of Health and Human Services and assistant dean for health policy and chief of health services research at the University of Florida. Dr. Graham holds a MD and a MPH from Yale University and did his medicine training at Massachusetts General Hospital and cardiology training at Johns Hopkins. His clinical interests are in population health management of cardiovascular disease, post PCI risk factor modification and health disparities.
Leanne Lefler is an Associate Professor in the College of Nursing, University of Arkansas for Medical Sciences. She is an Adult/Gerontology Clinical Nurse Specialist-BC, APRN, Fellow American Heart Association: Heart Disease Prevention & Physical Activity Interventions for Older Adults. Her research focuses on the prevention and early treatment of CHD in older adults.
Leanne Lefler is an Associate Professor in the College of Nursing, University of Arkansas for Medical Sciences. She is an Adult/Gerontology Clinical Nurse Specialist-BC, APRN, Fellow American Heart Association: Heart Disease Prevention & Physical Activity Interventions for Older Adults. Her research focuses on the prevention and early treatment of CHD in older adults.
Dr. Bangalore is an Associate Professor of Medicine at the New York University School of Medicine, NY, NY. He is the Director of Research for the Cardiac Catheterization laboratory and the Director of the Cardiovascular Outcomes group at NYU School of Medicine. He is a board certified interventional cardiologist with interest in complex coronary intervention. His research interests are in the areas of coronary artery disease and hypertension, including comparative effectiveness trials, prospective/retrospective studies and meta-analyses. In the field of coronary artery disease and acute coronary syndromes, his interest are in testing comparative effectiveness of treatment strategies in patients with
Dr. Bangalore is an Associate Professor of Medicine at the New York University School of Medicine, NY, NY. He is the Director of Research for the Cardiac Catheterization laboratory and the Director of the Cardiovascular Outcomes group at NYU School of Medicine. He is a board certified interventional cardiologist with interest in complex coronary intervention. His research interests are in the areas of coronary artery disease and hypertension, including comparative effectiveness trials, prospective/retrospective studies and meta-analyses. In the field of coronary artery disease and acute coronary syndromes, his interest are in testing comparative effectiveness of treatment strategies in patients with stable ischemic heart disease. In the field of hypertension, his interests are in the evaluation of optimal blood pressure goals in patients with and without CAD, treatment resistant hypertension including renal sympathetic denervation, evaluation of optimal role of beta blockers for cardioprotection and the optimal role for Renin Angiotensin Aldosterone blockers.
Jun Feng, MD and PhD is Assistant Professor of Surgery, Cardiovascular Research Center at Rhode Island Hospital, Alpert Medical School of Brown University. He is a clinical doctor with special training on cardiovascular surgery in China. He received his PhD in Cardiovascular Physiology from University of Montreal, Quebec, Canada. He is the Principal Investigator (PI) for two NIH-COBRE-Pilot Projects and Rhode Island Foundation. Dr. Feng also serves as co-investigators in multiple other funded research grants from National Institute of Health. He has published more than 105 peer-review/editorial articles/book chapters and 112 abstracts as first authors or co-authors. He
Jun Feng, MD and PhD is Assistant Professor of Surgery, Cardiovascular Research Center at Rhode Island Hospital, Alpert Medical School of Brown University. He is a clinical doctor with special training on cardiovascular surgery in China. He received his PhD in Cardiovascular Physiology from University of Montreal, Quebec, Canada. He is the Principal Investigator (PI) for two NIH-COBRE-Pilot Projects and Rhode Island Foundation. Dr. Feng also serves as co-investigators in multiple other funded research grants from National Institute of Health. He has published more than 105 peer-review/editorial articles/book chapters and 112 abstracts as first authors or co-authors. He has also served as editorial members or peer reviewers for a number of top ranking scientific journals in cardiovascular research and medicine. His research focuses on endothelial biology; coronary and peripheral microcirculation, myocardial apoptosis, mitochondria-related diseases, angiogenesis, heart failure, and cardiovascular diseases associated with metabolic syndrome, diabetes and related cellular and electrical signaling.
Dr. Marco Matteo Ciccone is working as Associate Professor in Bari University. He has successfully completed his Administrative responsibilities as Chief of the Angiology Ambulatory and Chief of the Specialization Course in Cardiovascular Diseases. His research has included a broad variety of medical subjects all related to cardiovascular diseases. He has authored more than 200 research articles/books. He is a member of Italian Society of Cardiology; Societa Italiana di Patologia Vascolare; Working Group on Peripheral Circulation European Society of Cardiology; working group on Peripheral Circulation of Italian Society of Cardiology; Societa Italiana di Flebologia clinica e sperimentale. His research interests
Dr. Marco Matteo Ciccone is working as Associate Professor in Bari University. He has successfully completed his Administrative responsibilities as Chief of the Angiology Ambulatory and Chief of the Specialization Course in Cardiovascular Diseases. His research has included a broad variety of medical subjects all related to cardiovascular diseases. He has authored more than 200 research articles/books. He is a member of Italian Society of Cardiology; Societa Italiana di Patologia Vascolare; Working Group on Peripheral Circulation European Society of Cardiology; working group on Peripheral Circulation of Italian Society of Cardiology; Societa Italiana di Flebologia clinica e sperimentale. His research interests include endothelial function, cardiovascular diseases, peripheral arterial diseases, vein thrombosis, non-invasive assessments.
Dr. Pinto received is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit. He has an active general and interventional cardiology practice and performs coronary, peripheral and structural heart intervention to including transeptal catheterization, transcatheter aortic valve replacement (TAVR) and percutaneous circulatory assist devices. Dr. Pinto was recently selected by his colleagues as one of the 'Best in Boston' for Interventional Cardiology and has also been selected for similar recognition by TopDoctors, Best Doctors and Castle Connolly Best Doctors.
Dr. Pinto received is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit. He has an active general and interventional cardiology practice and performs coronary, peripheral and structural heart intervention to including transeptal catheterization, transcatheter aortic valve replacement (TAVR) and percutaneous circulatory assist devices. Dr. Pinto was recently selected by his colleagues as one of the 'Best in Boston' for Interventional Cardiology and has also been selected for similar recognition by TopDoctors, Best Doctors and Castle Connolly Best Doctors.
Dr. Raouf A. Khalil is an Associate Professor in the Harvard Medical School, Brigham and Women′s Hospital, Division of Vascular Surger. His areas of expertise include Vascular Physiology and Cell Biology, Sex Hormones, Gender Differences in Vascular Disease, Pregnancy, Preeclampsia.
Mahboob Alam, MD, Assistant professor, is the director of interventional cardiology and interventional cardiology research at the Baylor Heart Clinic. Dr. Alam earned his medical degree from Aga Khan University Medical College in Karachi, Pakistan. His training includes an internship and residency in internal medicine at Baylor College of Medicine where he also completed his fellowship in interventional cardiology. Dr. Alam is board certified in interventional cardiology and cardiovascular disease and specializes in interventional cardiology, ischemic heart disease, coronary artery disease, peripheral arterial disease, percutanous coronary and peripheral intervention, acute myocardial infarction, hypertrophic obstructive cardiomyopathy, and valvular heart disease.His Research
Mahboob Alam, MD, Assistant professor, is the director of interventional cardiology and interventional cardiology research at the Baylor Heart Clinic. Dr. Alam earned his medical degree from Aga Khan University Medical College in Karachi, Pakistan. His training includes an internship and residency in internal medicine at Baylor College of Medicine where he also completed his fellowship in interventional cardiology. Dr. Alam is board certified in interventional cardiology and cardiovascular disease and specializes in interventional cardiology, ischemic heart disease, coronary artery disease, peripheral arterial disease, percutanous coronary and peripheral intervention, acute myocardial infarction, hypertrophic obstructive cardiomyopathy, and valvular heart disease.His Research Interests include: Acute coronary syndrome, High risk coronary interventions including left main stenting, Peripheral arterial disease, Valvular Heart Disease.
Dr. Rongxue Wu is currently a principal investigator at the University of Chicago.She received her Bachelor's and Master's degrees in Medicine from Kunming Medical School (China),and received her MD and PhD at Wurzburg University (Germany). She completed her postdoctoral training at Northwestern University. Her research focuses on mechanisms of heart failure, especially on how alterations in fat metabolism and endothelial dysfunction contribute to cardiovascular disease in diabetes. She has been published in several leading journals, including The Journal of Clinical Investigation, Circulation Research, and EMBO Molecular Medicine. She currently serves as a peer reviewer for the AHA Lipids Basic Science 2
Dr. Rongxue Wu is currently a principal investigator at the University of Chicago.She received her Bachelor's and Master's degrees in Medicine from Kunming Medical School (China),and received her MD and PhD at Wurzburg University (Germany). She completed her postdoctoral training at Northwestern University. Her research focuses on mechanisms of heart failure, especially on how alterations in fat metabolism and endothelial dysfunction contribute to cardiovascular disease in diabetes. She has been published in several leading journals, including The Journal of Clinical Investigation, Circulation Research, and EMBO Molecular Medicine. She currently serves as a peer reviewer for the AHA Lipids Basic Science 2 Committee. Throughout her career, she has been honored with several prestigious accolades. She received the Chinese Government Award for Outstanding Chinese Student Studying Abroad, and placed first in the Rudolf Thauer Poster Prize Competition, hosted by the German Society for Cardiology. She has also received a Postdoctoral Fellowship and Scientist Development Grant from the AHA.
Sahar S. Abdelmoneim is an Assistant Professor of Medicine and a Research Associate in the Department of Medicine, Cardiovascular Diseases Division, Cardiac Ultrasound and Hemodynamic Laboratory at Mayo Clinic, Rochester, Minnesota. She is also an Assistant Lecturer of Cardiology at Assiut University in Egypt. Her research interests include: Application of contrast perfusion echocardiography in Acute coronary syndrome and in Diabetes Mellitus, Novel technologies in Echocardiography (3D echo and strain) and Stress Echocardiography, Cancer cardiotoxicity and Novel Echocardiographic Imaging techniques, Noninvasive diagnostic testing for heart diseases in women, Heath-related quality of life evaluation in women, Evidence-based medicine and systematic review and
Sahar S. Abdelmoneim is an Assistant Professor of Medicine and a Research Associate in the Department of Medicine, Cardiovascular Diseases Division, Cardiac Ultrasound and Hemodynamic Laboratory at Mayo Clinic, Rochester, Minnesota. She is also an Assistant Lecturer of Cardiology at Assiut University in Egypt. Her research interests include: Application of contrast perfusion echocardiography in Acute coronary syndrome and in Diabetes Mellitus, Novel technologies in Echocardiography (3D echo and strain) and Stress Echocardiography, Cancer cardiotoxicity and Novel Echocardiographic Imaging techniques, Noninvasive diagnostic testing for heart diseases in women, Heath-related quality of life evaluation in women, Evidence-based medicine and systematic review and meta-analysis methodology
Dr. Dong Wang is an Assistant Professor of Medicine at the University of Tennessee. He received his M.D and Ph.D at Beihua University and Peking Union Medical Collage in China. He is currently a principal investigator and his research is aimed at uncovering the role of Corin-atrial natriuretic peptide (ANP) system in myocardial infarction and heart failure. He has published his work in high-impact, peer reviewed journals in cardiovascular research field, such as Circulation, Circulation Research and Hypertension. He was granted with Leonard Share Young Investigator Award for outstanding basic science research in the Cardiovascular-Renal field in the University of
Dr. Dong Wang is an Assistant Professor of Medicine at the University of Tennessee. He received his M.D and Ph.D at Beihua University and Peking Union Medical Collage in China. He is currently a principal investigator and his research is aimed at uncovering the role of Corin-atrial natriuretic peptide (ANP) system in myocardial infarction and heart failure. He has published his work in high-impact, peer reviewed journals in cardiovascular research field, such as Circulation, Circulation Research and Hypertension. He was granted with Leonard Share Young Investigator Award for outstanding basic science research in the Cardiovascular-Renal field in the University of Tennessee and his research is currently supported by Scientist Development Grant from the American Heart Association.
Dr. Yutao Xi, MD., PhD is an Assistant Professor of Medicine in the University of Texas School of Medicine at Houston. His research interest include cardiology.
Dr. Nassim Krim is a cardiologist in Bronx, New York and is affiliated with multiple hospitals in the area, including Bronx-Lebanon Hospital Center Health Care System and Montefiore Medical Center. He received his medical degree from University of Algiers Faculty of Medicine and has been in practice for 14 years. Research intersts include: Peripheral Vascular Diseases; Myocardial Infarction; Vasodilator Agents; Hospitalization; Coronary Vasospasm; Treatment Outcome; Intra-Arterial Injections; Coronary Vessels; Coronary Angiography
Dr. Nassim Krim is a cardiologist in Bronx, New York and is affiliated with multiple hospitals in the area, including Bronx-Lebanon Hospital Center Health Care System and Montefiore Medical Center. He received his medical degree from University of Algiers Faculty of Medicine and has been in practice for 14 years. Research intersts include: Peripheral Vascular Diseases; Myocardial Infarction; Vasodilator Agents; Hospitalization; Coronary Vasospasm; Treatment Outcome; Intra-Arterial Injections; Coronary Vessels; Coronary Angiography
Dr. Olga McDaniel, MT, PHD is a Professor of Surgery with secondary appointments in the Departments of Neurology and Pathology at UMMC. She is Principal Investigator and Coordinator of Transplantation Immunogenetics/DNA Diagnostics Laboratory (TIDDL) in the Department of Surgery. The TIDDL activities are 20-30% devoted to the molecular diagnosis of neurodegenerative disease and HLA genotyping for disease. She is known as a Research Educator to the Faculty, Residents, and Medical students in the Department of Surgery. Much of her research work has been in the field of immunogenetics of diseases, human allograft transplantation, genomics of trauma-induced injuries and genotyping studies
Dr. Olga McDaniel, MT, PHD is a Professor of Surgery with secondary appointments in the Departments of Neurology and Pathology at UMMC. She is Principal Investigator and Coordinator of Transplantation Immunogenetics/DNA Diagnostics Laboratory (TIDDL) in the Department of Surgery. The TIDDL activities are 20-30% devoted to the molecular diagnosis of neurodegenerative disease and HLA genotyping for disease. She is known as a Research Educator to the Faculty, Residents, and Medical students in the Department of Surgery. Much of her research work has been in the field of immunogenetics of diseases, human allograft transplantation, genomics of trauma-induced injuries and genotyping studies in different populations.
Dr. Hua Zhu is an Assistant Professor in the Davis Heart And Lung Research Institute, The Ohio State University. He has completed his postdoctoral Fellowship during 2006-2011, in the University of Medicine and Dentistry of New Jersey. His research interests include Muscular dystrophy, stem cell protection for treatment of ischemic heart diseases, molecular mechanisms of corneal wound healing.
Dr. Hua Zhu is an Assistant Professor in the Davis Heart And Lung Research Institute, The Ohio State University. He has completed his postdoctoral Fellowship during 2006-2011, in the University of Medicine and Dentistry of New Jersey. His research interests include Muscular dystrophy, stem cell protection for treatment of ischemic heart diseases, molecular mechanisms of corneal wound healing.
Phani Veeranki is an Assistant Professor of Epidemiology in the Department of Preventive Medicine and Community Health at the University of Texas Medical Branch, Galveston. Dr.Veeranki received his medical degree from the N.T.R University of Health Sciences, his MPH from the University of Illinois and his DrPH with specialization in epidemiology from the East Tennessee State University College of Public Health. He also completed a fellowship in pediatric health outcomes research at the Vanberbilt University Medical Center. His interest is in understanding 'The early origins of disease' with focus on the prevention and control of chronic diseases. His current research
Phani Veeranki is an Assistant Professor of Epidemiology in the Department of Preventive Medicine and Community Health at the University of Texas Medical Branch, Galveston. Dr.Veeranki received his medical degree from the N.T.R University of Health Sciences, his MPH from the University of Illinois and his DrPH with specialization in epidemiology from the East Tennessee State University College of Public Health. He also completed a fellowship in pediatric health outcomes research at the Vanberbilt University Medical Center. His interest is in understanding 'The early origins of disease' with focus on the prevention and control of chronic diseases. His current research interests include chronic disease epidemiology, epidemiology of respiratory and cardiovascular diseases, adolescent tobacco use behaviors, pediatric epidemiology, pharmacoepidemiology and global health.
Dr. Dasari is an Assistant Professor at the University of Oklahoma Health Sciences Center. He finished his internship, residency and fellowship from OUHSC and an additional fellowship in advanced heart failure and transplantation from Loyola University Medical Center, Illinois. His research interests include Atherosclerotic diseases and treatment, Advanced heart failure.
Dr. Dasari is an Assistant Professor at the University of Oklahoma Health Sciences Center. He finished his internship, residency and fellowship from OUHSC and an additional fellowship in advanced heart failure and transplantation from Loyola University Medical Center, Illinois. His research interests include Atherosclerotic diseases and treatment, Advanced heart failure.
Dr. Zhou received his Ph.D in Medical Science from Peking University and completed his Postdoctoral study from Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Currently he is working as a research Assistant Professor in Biology and Medicineat the Warren Alpert Medical School of Brown University. Dr. Zhou′s projects focus on developing RNA-based biomarker for arrhythmia risk stratification and RNA-based arrhythmia therapeutics.
Dr. Zhou received his Ph.D in Medical Science from Peking University and completed his Postdoctoral study from Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Currently he is working as a research Assistant Professor in Biology and Medicineat the Warren Alpert Medical School of Brown University. Dr. Zhou′s projects focus on developing RNA-based biomarker for arrhythmia risk stratification and RNA-based arrhythmia therapeutics.
Dr.Karam Turk-Adawi is an Assistant Professor of Health Policy at York University. Dr. Turk-Adawi also holds a research role at the University Health Network, Toronto, Canada, where she leads the survey of cardiac rehabilitation programs in Arab countries, with the International Council of Cardiovascular Prevention and Rehabilitation. Her main research interests include preventive cardiology (primary and secondary prevention) with a focus on cardiac rehabilitation, health-quality and outcomes research in patients with cardiovascular diseases, global health research in cardiovascular disease prevention,health disparities, health services research, and health policy.
Dr.Karam Turk-Adawi is an Assistant Professor of Health Policy at York University. Dr. Turk-Adawi also holds a research role at the University Health Network, Toronto, Canada, where she leads the survey of cardiac rehabilitation programs in Arab countries, with the International Council of Cardiovascular Prevention and Rehabilitation. Her main research interests include preventive cardiology (primary and secondary prevention) with a focus on cardiac rehabilitation, health-quality and outcomes research in patients with cardiovascular diseases, global health research in cardiovascular disease prevention,health disparities, health services research, and health policy.
Giuseppe Tarantini graduated in Medicine and Surgery at the University of Parma in 1997; he obtained a Postgraduate Diploma in Cardiology at the University of Padua in 2001. In 2005 he received the PhD in Experimental and Cardiological Sciences at the Department of Clinical and Experimental Medicine at the same University. His fields of interest include Ischemic heart disease, valvular heart disease, cardiomyophaties.
Giuseppe Tarantini graduated in Medicine and Surgery at the University of Parma in 1997; he obtained a Postgraduate Diploma in Cardiology at the University of Padua in 2001. In 2005 he received the PhD in Experimental and Cardiological Sciences at the Department of Clinical and Experimental Medicine at the same University. His fields of interest include Ischemic heart disease, valvular heart disease, cardiomyophaties.
Prof. Oscar Lorenzo has received his PhD in 2001 at the Autonoma University (Madrid). Currently, he is working as principal investigator in the Cardiovascular Research Laboratory at the Autonoma University. His research has included studies in hypertension and diabetes effects on the cardiovascular system. Based on this research and fellowship training he has received several awards and honours, such as: BIAL European Awards in 2000. He is serving as expert reviewer for journals like International J Cardiology, J Mol Cell Cardiol, Diabetology and M.S, Cardiovasc Diabetol, J hypertension, Am J Physiol Heart. He has authored more than fifty research articles/books.
Prof. Oscar Lorenzo has received his PhD in 2001 at the Autonoma University (Madrid). Currently, he is working as principal investigator in the Cardiovascular Research Laboratory at the Autonoma University. His research has included studies in hypertension and diabetes effects on the cardiovascular system. Based on this research and fellowship training he has received several awards and honours, such as: BIAL European Awards in 2000. He is serving as expert reviewer for journals like International J Cardiology, J Mol Cell Cardiol, Diabetology and M.S, Cardiovasc Diabetol, J hypertension, Am J Physiol Heart. He has authored more than fifty research articles/books. He has been a member of national societies and networks of Diabetes and Cardiology, and was honoured as Professor of Research in 2011.
Fabio Angeli working as investigator and co-responsible for planning and management of mono-centre and multi-centre Clinical Studies on Cardiovascular Drugs (in connection with Hospitals and Universities). Aiuto of Division of Cardiology in the Setting of the Cardiovascular Department of University Hospital of Perugia with CCU, Cath Lab, Cardiac Surgery, Echo Lab, Electrophysiol Lab and Out-patient clinic (Italian National Health System, Italy). Medical Writing. His main areas of interests include, Cardiovascular risk assessment in patients with hypertension, diabetes, heart failure and coronary artery disease Evaluation of cardiovascular treatment.
Fabio Angeli working as investigator and co-responsible for planning and management of mono-centre and multi-centre Clinical Studies on Cardiovascular Drugs (in connection with Hospitals and Universities). Aiuto of Division of Cardiology in the Setting of the Cardiovascular Department of University Hospital of Perugia with CCU, Cath Lab, Cardiac Surgery, Echo Lab, Electrophysiol Lab and Out-patient clinic (Italian National Health System, Italy). Medical Writing. His main areas of interests include, Cardiovascular risk assessment in patients with hypertension, diabetes, heart failure and coronary artery disease Evaluation of cardiovascular treatment.
Gaetano Santulli, MD, PhD is a principal investigator currently working at Columbia University. A physician-scientist. Dr. Santulli completed his postdoctoral training at Columbia University Medical Center in New York City, supported by an American Heart Association (AHA) fellowship and a Scientist Development Grant. His expertise comprises both clinical and basic research topics, including hypertension, diabetes, heart failure, arrhythmias, vascular disease, microRNA, and mitochondrial pathophysiology. He is a member of several international academic societies, including AHA, American Association for the Advancement of Science (AAAS), New York Academy of Sciences (NYAS), American Diabetes Association (ADA), European Association of Heart Failure, European Association
Gaetano Santulli, MD, PhD is a principal investigator currently working at Columbia University. A physician-scientist. Dr. Santulli completed his postdoctoral training at Columbia University Medical Center in New York City, supported by an American Heart Association (AHA) fellowship and a Scientist Development Grant. His expertise comprises both clinical and basic research topics, including hypertension, diabetes, heart failure, arrhythmias, vascular disease, microRNA, and mitochondrial pathophysiology. He is a member of several international academic societies, including AHA, American Association for the Advancement of Science (AAAS), New York Academy of Sciences (NYAS), American Diabetes Association (ADA), European Association of Heart Failure, European Association of Echocardiography, Acute Cardiovascular Care Association, European Association of Percutaneous Cardiovascular Interventions; European Society of Cardiology (ESC), Working Groups on Hypertension & the Heart, Cardiac Cellular Electrophysiology, Myocardial Function, Cellular Biology of the Heart.
Dr. Galya Naydenova Atanasova is a Cardiologist at Pleven Medical University, Bulgaria. She has over thirty publications in various Journals. Completed cardiology training at Dokuz Eylul University, Izmir, Turkey in 2012. Research interests include Preventive Cardiology, Regenerative Biology Research, Deciphering the molecular and Cellular Mechanisms, Maintenance and Differentiation of Cardiovascular Progenitors, Translational Cardiovascular Genetics, and Proteomic Analysis of Heart Disease.
Dr. Galya Naydenova Atanasova is a Cardiologist at Pleven Medical University, Bulgaria. She has over thirty publications in various Journals. Completed cardiology training at Dokuz Eylul University, Izmir, Turkey in 2012. Research interests include Preventive Cardiology, Regenerative Biology Research, Deciphering the molecular and Cellular Mechanisms, Maintenance and Differentiation of Cardiovascular Progenitors, Translational Cardiovascular Genetics, and Proteomic Analysis of Heart Disease.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97